Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Single-Cell Genome Sequencing Market Covering 2025–2034?
The single-cell genome sequencing market has witnessed significant growth in recent years. This market is projected to expand from $2.49 billion in 2024 to $2.83 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.6%. The historical growth can be linked to factors such as an enhanced understanding of genetic heterogeneity, the increasing demand for precision medicine, augmented cancer research, a rise in the prevalence of infectious diseases, and greater healthcare spending.
The single-cell genome sequencing market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.02 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.4%. Several factors contribute to this growth during the forecast period, including the rising incidence of autoimmune diseases and neurological disorders, increased government support and funding, the emergence of contract research organizations (CROs), and a greater understanding of scRNA-seq’s capabilities. Key developments expected during this period involve technological progress in single-cell sequencing, the evolution of single-cell multi-omics technologies, cooperative efforts to expedite advancements, novel solutions, and collaborations among major industry participants.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
What Are The Key Drivers Of Growth In The Single-Cell Genome Sequencing Market?
The increasing prevalence of cancer is expected to drive the growth of the single-cell genome sequencing market. Cancer is characterized by aberrant cells that develop and divide uncontrollably, stemming from alterations in genes that regulate cell division and normal cellular function. As cancer is fundamentally a disease involving genetic changes, single-cell genome sequencing is instrumental in uncovering these genetic modifications within individual cancer cells. For instance, according to the American Cancer Society, a US-based cancer-fighting organization, around 1.9 million new cancer cases and 609,360 cancer deaths were recorded in the US in 2022, as reported in January 2023. Furthermore, it is estimated that approximately 27.5 million new cancer cases and 16.3 million cancer deaths will occur by 2040. Therefore, the rising occurrence of cancer is anticipated to propel the single-cell genome sequencing market forward.
What Are The Major Segment Categories Driving The Single-Cell Genome Sequencing Market Growth?
The single-cell genome sequencingmarket covered in this report is segmented –
1) By Type: Instruments; Reagents
2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Quantitative Polymerase Chain Reaction (qPCR); Microarray; Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer; Immunology; Prenatal Diagnosis; Neurobiology; Microbiology; Other Disease Areas
4) By Application: Circulating Cells; Cell Differentiation Or Reprogramming; Genomic Variation; Subpopulation Characterization; Other Applications
5) By End User: Academic Research Laboratories; Biotechnology Biopharmaceutical Companies; Clinics; Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems; Sequencing Platforms; Automation And Robotic Systems
2) By Reagents: Library Preparation Kits; Amplification Reagents; DNA Extraction Kits; Quality Control Reagents
What Long-Term Trends Will Shape The Future Growth Of The Single-Cell Genome Sequencing Industry?
Technological advancements stand out as a key trend gaining significant traction within the single-cell genome sequencing market. Prominent companies active in the single-cell genome sequencing market are concentrating their efforts on developing technologically sophisticated solutions to bolster their market position. For instance, in May 2023, Mission Bio Inc., a US-based single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development, introduced the Tapestri Genome Editing Solution. This new end-to-end product is designed for the comprehensive analysis of genome editing. The novel methodology is anticipated to function as a more effective analytical instrument for developing next-generation gene-edited drugs by providing single-cell insights that have the potential to influence efficacy and safety.
Which Leading Players Are Enhancing Their Single-Cell Genome Sequencing Market Presence Worldwide?
Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Region Shows The Highest Potential For Future Expansion In The Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Single-Cell Genome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp
Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2025, By The Business Research Company
Genome Editing Or Genome Engineering Global Market Report 2025
Cell Culture Consumables And Equipment Global Market Report 2025
Cell Based Assays Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model